Antibodies and Vaccines as Drugs for COVID-19
Por um escritor misterioso
Descrição
Most Inflammatory Disease Patients on Immunosuppressants Mount a Response to the COVID-19 Vaccine
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies, Journal of Biomedical Science
The anti–SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination
Research related to COVID-19 (Updated April 1, 2022)
Vaccines, Free Full-Text
Antibodies and Vaccines as Drugs for COVID-19
Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario - Ontario COVID-19 Science Advisory Table
Development of vaccines and antivirals for combating viral pandemics
9 Things You Need To Know About Molnupiravir, a New COVID-19 Pill > News > Yale Medicine
Small molecules, antibodies, and vaccines: using biology to fight COVID-19 - Mammoth Biosciences
How Effective Are COVID-19 Vaccines in Immunocompromised People?
Can artificial intelligence help us design vaccines?
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies, Journal of Biomedical Science
de
por adulto (o preço varia de acordo com o tamanho do grupo)
